Division of Nephrology and Hypertension, University of California Irvine, Irvine, CA, USA.
Transl Res. 2012 Oct;160(4):309-18. doi: 10.1016/j.trsl.2012.03.003. Epub 2012 Apr 6.
Endoplasmic reticulum (ER) is the site of synthesis, folding, assembly, and degradation of proteins. Disruption of ER function leads to ER stress, which is marked by accumulation of unfolded proteins in the ER lumen. Detection of unfolded proteins by the ER membrane receptors triggers the "unfolded protein response (UPR)" designed to restore ER function via activation of the adaptive/cytoprotective responses. Failure of UPR or persistent stress triggers activation of ER stress-mediated apoptotic pathway. Several in vivo and in vitro studies have demonstrated the association of ER stress with glomerular diseases. Imai rats develop progressive glomerulosclerosis (GS), which is associated with oxidative stress, inflammation and activation of intra-renal angiotensin system, and can be prevented by AT-1 receptor blockade (ARB). Since persistent oxidative and inflammatory stresses trigger ER stress-induced apoptosis and tissue injury, we hypothesized that kidneys in the Imai rats may exhibit failure of the adaptive and activation of the apoptotic ER stress responses, which could be prevented by ARB. To this end 10-week old Imai rats were randomized to untreated and ARB-treated groups and observed for 24 weeks. At age 34 weeks, untreated rats showed heavy proteinuria, azotemia, advanced GS, impaired ER stress adaptive/cytoprotective responses (depletion of UPR-mediating proteins), and activation of ER stress apoptotic responses. ARB treatment attenuated GS, suppressed intra-renal oxidative stress, restored ER-associated adaptive/cytoprotective system, and prevented the ER stress mediated apoptotic response in this model. Thus, progressive GS in Imai rats is accompanied by activation of ER stress-associated apoptosis, which can be prevented by ARB.
内质网(ER)是蛋白质合成、折叠、组装和降解的场所。ER 功能的破坏导致 ER 应激,其特征是未折叠蛋白质在 ER 腔中积累。未折叠蛋白质被 ER 膜受体检测到会触发“未折叠蛋白反应(UPR)”,该反应旨在通过激活适应性/细胞保护反应来恢复 ER 功能。UPR 失败或持续应激会触发 ER 应激介导的凋亡途径的激活。一些体内和体外研究表明 ER 应激与肾小球疾病有关。Imai 大鼠发展为进行性肾小球硬化症(GS),其与氧化应激、炎症和肾内血管紧张素系统的激活有关,可通过 AT1 受体阻断剂(ARB)预防。由于持续的氧化和炎症应激会引发 ER 应激诱导的细胞凋亡和组织损伤,我们假设 Imai 大鼠的肾脏可能会出现适应性失败和凋亡 ER 应激反应的激活,ARB 可预防这种情况。为此,10 周龄的 Imai 大鼠被随机分为未治疗组和 ARB 治疗组,并观察 24 周。在 34 周龄时,未治疗组大鼠出现大量蛋白尿、氮质血症、晚期 GS、UPR 介导蛋白耗竭导致的适应性/细胞保护反应受损,以及 ER 应激凋亡反应激活。ARB 治疗减轻了 GS,抑制了肾内氧化应激,恢复了与 ER 相关的适应性/细胞保护系统,并防止了该模型中 ER 应激介导的凋亡反应。因此,Imai 大鼠的进行性 GS 伴有 ER 应激相关的细胞凋亡激活,ARB 可预防这种情况。